InMed Pharmaceuticals Inc. , a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announces the launch of.
Shares of InMed Pharmaceuticals Inc. (TSE:IN – Get Free Report) were down 1.6% during mid-day trading on Monday . The stock traded as low as C$4.13 and last traded at C$4.19. Approximately 17,035 shares changed hands during trading, a decline of 42% from the average daily volume of 29,552 shares. The stock had previously closed […]
Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) and InMed Pharmaceuticals (NASDAQ:INM – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, dividends, risk, profitability and institutional ownership. Analyst Recommendations This is a breakdown of […]
InMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
InMed Pharmaceuticals: InMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.